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Summary.-Permanent changes in the endocrine status of female SJL/J and CR
mice were induced by masculinization, ablation of endocrine glands, inoculation
of hormones, or feeding of the chemical carcinogen DMBA. All these prodecures
resulted in modification of the host hormonal milieu, as shown by blood hormone
determination. Masculinization reduced drastically the onset of lymphosarcoma
and increased the incidence of systemic neoplasms respectively in DMBA-treated
female SJL/J and CR mice. Continued administration of gonadotrophins increased
the incidence of systemic neoplasia in CR mice. A direct correlation is suggested
between onset of lymphosarcoma or other tumours in mice and a specific shift to
an abnormal hormonal environment.
UNIDENTIFIED host factors seem to in-
fluence or control the proliferation of
pre-leukaemic cells present in different
organs of mice treated with chemical
carcinogens (Haran-Ghera, 1973). Speci-
fic endocrine disorders have recently
been found in SJL/J mice (Pierpaoli et
al., 1974), a strain developing a high
incidence of spontaneous reticulum-cell
neoplasms (Murphy, 1963), classified as
Type B (RCN-B) by Dunn (1954). These
mice also develop lymphosarcomas (LS)
in high incidence after oral treatment
with the chemical carcinogen 7,12-di-
methylbenzanthracene (DMBA) (Haran-
Ghera, Kotler and Meshorer, 1967). On
the basis of the abnormal endocrine
pattern present in SJL/J mice, it has
been proposed that chronic congenital or
induced endocrine derangements (Pier-
paoli et al., 1974; Pierpaoli and Haran-
Ghera, 1975) might be determinants in
the emergence and proliferation of " dor-
mant " pre-leukaemic cells and the type
of systemic neoplasms that ensue. Such
an association between endocrine derange-
ments and leukaemogenesis had already
been strengthened by recent data showing
a striking decrease in the incidence of
leukaemia in mice whose hypophyseal
function had been inhibited or depressed
by antiadenohypophysis (anti-AH) anti-
bodies (Pierpaoli and Haran-Ghera, 1975).
The present work seeks to clarify
further the relationship between the host
humoral status and onset of systemic
neoplasms in mice. Permanent hormonal
derangements have been induced in mice
by various means, and the correlation
between a particular abnormal hormonal
status and onset of LS and RCN has been
studied.
MATERIAL AND METHODS
Animals
Inbred SJL/J and C57BL/6 mice were
obtained from the Animal Breeding Centre
oftheWeizmannInstituteofScience,Rehovot,
Israel. Other batches of the same strains
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of mice were supplied by the Institute for
Biological and Medical Research of Hoff-
mann-La Roche AG, Fullinsdorf, Switzer-
land. Inbred BALB/c mice were obtained
from GI. Bomholtgard, Laboratory Animals
and Research Centre, Ry, Denmark. Out-
bred Charles River (CR) mice were pur-
chased from Wander AG, Bern, Switzerland.
All groups of mice used for experimentation
were kept in conventional conditions in
air-conditioned quarters, either in the Weiz-
mann Institute of Science or in the animal
house of this Institute.
Hormonal manipulations and operations
(a) Gonadectomy and thymectomy.-Ovaries
were removed from 1-month-old SJL/J mice
which had been thymectomized or sham-
thymectomized 1 week earlier.
(b) Masculinization of females.-Perma-
nent masculinization and sterilization of
SJL/J and CR females were induced by
a single injection of 1 mg testosterone
propionate in peanut oil, between 1 and
3 days of age (Barraclough and Leathem,
1954; Barraclough, 1961a, b). Controls were
injected with oil only. This procedure inter-
feres with the normal onset of cyclicity in
females, which will be permanently sterile
and develop a masculine hormonal environ-
ment (Barraclough, 1961a, b).
(c) Inoculation ofhormones.-Growth hor-
mone (bovine, NIH-GH-B15 and B16) and
thyroid-stimulating hormone (bovine, NIH-
TSH-B5) generously supplied by the Na-
tional Institute of Arthritis and Metabolic
Diseases, through the Pituitary Hormone
Distribution Program, and Human Chorionic
Gonadotropin (HCG, Pregnyl, NV-Organon,
Holland) were used.
(d) Oral administration of 7,12-dimethyl-
benzanthracene (DMBA).-Five feedings of
1 mg each of DMBA in polyethylene glycol-
400 were administered at weekly intervals.
It has been shown that DMBA induces
rapid onset of lymphosarcoma in SJL/J mice
(Haran-Ghera et al., 1967). The drug also
produces striking alterations in adrenal
and gonadal function, as shown by previous
investigations (Dale and Scutchfield, 1968;
Krarup, 1970) and by our present findings.
Hormone determinations
All mice were bled at monthly intervals
in the morning (9-11 a.m.) under strictly
standardized conditions. They were rapidly
anaesthesized with ether, and blood collected
from the retro-orbital plexus with a Pasteur
pipette. Sera of 5-10 mice were pooled,
divided into aliquots and stored at -20°C
until hormones were measured. Blood levels
of progesterone, 17-p-oestradiol, cortico-
sterone and thyroxine were determined
(Abraham, 1969, 1974; Buus, 1968; Murphy
and Jachan, 1965; Murphy, Pattee and Gold
1966). Some radioimmunoassays of luteo-
trophic hormone (LH) and prolactin were
also performed. Double determinations of
coded sera from the different pools were
performed. Standard deviations did not
exceed 10%. The rat kits for radioimmuno-
assays were a gift from the National Institute
of Arthritis, Metabolism and Digestive
Diseases, Rat Pituitary Hormone Distribu-
tion Program, Bethesda, Maryland, USA
(Rat-LH 1-3; Rat Prolactin-I-1). Cross-
reactivity with reference samples of mouse
LH was also tested.
Effect of GH and TSH on DMBA-induced
leukaemia in SLJ/J mice (Exp. 1)
Three groups of SJL/J female mice
were all fed once a week for 5 weeks with
DMBA, starting at 40 days of age. After
termination of the DMBA treatment, one
group was injected s.c. 5 x /week with 200
,ug GH, one group with 200 jig TSH and
one control group with a non-hormonal
protein, bovine serum albumin (BSA). The
treatment with hormones or BSA was
continued until tumours developed. Inci-
dence and average latent period (ALP)
for onset of lymphosarcoma were calculated.
Thymectomy, gonadectomy and incidence of
RCN-B in SJL/J mice (Exp. 2)
Four groups of one-month-old female
SJL/J mice were thymectomized and/or
gonadectomized or sham-operated at 30 days
of age (prepubertal). ALP and incidence
of RCN-B and leukaemia were recorded.
Gonadectomy and spontaneous RCN-B in
SJL/J mice (Exp, 3)
Two groups of female SJL/J mice were
gonadectomized or sham-operated between
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80 and 100 days of age (postpubertal).
Incidence and ALP of RCN-B were recorded.
Gonadectomy and DMBA-induced leukaemia
in SJL/J mice; hormone level,s (Exp. 4)
Two groups of SJL/J female mice were
used. When between 60 and 80 days of
age one group was gonadectomized and
given 5 feedings of DMBA, and one group
was given DMBA only. At 120, 150, 210
and 240 days of age, they were bled for
determinations of hormones in blood. Inci-
dence and ALP of leukaemia were also
recorded.
Masculinization and spontaneous RCN-B or
DMBA-induced leukaemia in SJL/J mice
(Exp. 5)
Four groups of SJL/J female mice were
used. At 2 or 3 days of age, 2 groups were
injected s.c. with 1 mg testosterone pro-
pionate in peanut oil, and 2 groups with
oil only. Starting at 60 days of age, 2
groups were fed with DMBA. Onset and
ALP of leukaemia and/or RCN-B were
recorded.
Masculinization and DMBA-induced tumours
in CR mice (Exp. 6)
Four groups of CR female mice were
used. At 1 day of age, 2 groups were
injected s.c. with 1 mg TP, and 2 groups
with oil only. The feeding with DMBA was
started in 2 groups at 30 days ofage. Levels
of hormones were evaluated at 70, 150, 180,
210 and 360 days of age. Onset of tumours
and ALP for their appearance were recorded.
Gonadotrophins and tumours (Exp. 7)
Two groups of female CR mice were
injected s.c. 5 x /week with 300 jg HCG
or human serum albumin (HSA), starting
at 50 days of age. The treatment was
continued for over 2 years and interrupted
in individual mice when tumours were
visible or palpable. Onset of tumours and
ALP were recorded.
Gonadotrophins and DMBA-induced tumours
(Exp. 8)
Four groups of female CR mice were
used. Two groups were fed 5x at weekly
intervals with DMBA, starting at 50 days
of age. Starting at the same age, one of
the DMBA-treated groups and one untreated
group were chronically inoculated 5 x /week
with 200 ,tg HCG. The treatment was
maintained until the animals developed
visible or palpable tumours. Appearance
and ALP of tumours were recorded.
Histology
In almost all cases, neoplastic tissues
were removed and examined histologically
for a precise microscopical diagnosis. The
diagnosis was not ascertained histologically
in very few cases of early appearance of
LS in the thymus of DMBA-treated SJL/J
mice (Exps 4 and 5). Tissues were fixed
in Bouin's fluid, embedded in paraffin.
Sections were stained with haematoxylin-
eosin.
RESULTS
Experiment 1
As shown in Table I, treatment with
GH and TSH in DMBA-treated SJL/J
mice did not significantly affect incidence
of LS. It only slightly shortened ALP
for onset of LS when the mice were
treated with GH.
Experiments 2 and 3
As already shown in previous work
(Haran-Ghera et al., 1967), removal of
TABLE I.-Effect ofGrowth Hormone (GH) and Thyrotrophic Hormone (TSH) on DMBA-
induced Lymphosarcomas (LS) in SJL/J Mice
Incidence of ALPt LS Incidence of ALPt RCN-Bt
Treatment* LS (days) RCN-B$ (days)
DMBA+GH 25/29=860% 111 1/29=3% 230
DMBA+TSH 14/19 =73% 135 4/19 =21% 192
DMBA+BSA 16/19 =84% 138 2/19= 11% 195
* Hormones or bovine serum albumin (BSA) were injected 5 x /week at a daily dose of 200 ,ug/mouse.
t Average Latent Period.
t Reticulum-Cell Neoplasm, type B.
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ovaries in SJL/J mice at 30 or 80-100
days of age did not significantly affect
ALP and incidence of RON-B. Thymec-
tomy at 30 days of age prolongs ALP,
and slightly affects incidence of RCN-B
(Table II).
TABLE II.-Effect of Thymectomy and/or
Ovariectomy on Onset of Spontaneous
Reticulum-cell Neoplasms in SJL/J mice
Host treatment
Untreated
Ovariectomy*
Thymectomy
Thym. +ovariectomy*
Untreated
Ovariectomyt
Incidence
28/35=80%
27/30=90%
22/31 =70%
24/33= 72%
59/60=98%
55/61 =90%
ALP
(days)
380
388
449
409
339
378
* Ovariectomy at 30 days of age.
t Ovariectomy at 80-100 days of age.
Experiment 4
The incidence of LS was reduced in
SJL/J mice ovariectomized at 30 days
of age and treated with DMBA. Castra-
tion also slightly prolonged the ALP
(Table III). However, as was shown in
Table II, gonadectomy per se did not
affect the incidence of RON-B. In fact,
the mice in which castration prevented
the onset of DMBA-induced leukaemia
later developed RCN-B with an incidence
equal to that of non-castrated SJL/J
mice (Table II and III). Feeding with
DMBA increased remarkably the blood
levels of corticosterone. However, the
level of this hormone was subnormal
later in life in DMBA-treated mice (Table
IV). Levels of progesterone were con-
stantly reduced by DMBA treatment,
and this diminution was also maintained
later in life. A remarkable decrease of
17-,1-oestradiol and progesterone was ob-
served in DMBA-treated mice at 210 days
of age. Levels of thyroxine were not
significantly affected. DMBA treatment
induced a very significant and durable
increase in levels of LH, while levels of
prolactin were slightly affected (Table
IV). Surprisingly, at 240 days of age,
DMBA treatment induced a sharp increase
of progesterone in blood of castrated
TABLE III.-Lower Incidence of Lymphosarcoma in Ovariectomized and DMBA-treated
SJL/J Mice
ALP
Host treatment
DMBA
Ovariectomy+DMBA
Incidence
39/51_ 76%> (p< - 1)
15/39-38%~ P001
(days)
209> (p<001) 238> P~01
The significance of the difference in tumour incidence was estimated from the x2 test. The significance
of the difference in ALP was estimated from the Mann-Whitney test.
TABLE IV.-Chanyes of Hormone Levels in Peripheral Blood of Female SJL/J Mice*
Consequent to Ovariectomy (Gx) and/or Treatment with DMBA
A __ r
Treatment
DMBA
Gx
Gx+DMBA
DMBA
DMBA
DMBA
Gx
Gx+DMBA
Thyroxine Corticosterone Progesterone 17-fl-Oestradiol LH
jsg/100 ml jg/100 ml jcg/100 ml nm ng/ml
9-3 0-63 - 38
10-9 - 0-38 160
7-27 0-20
13 - 77 0.10
8-6 8 30 0 60 0 48 49
10.1 11-20 0-36 0-56 130
5-9 6-80 0-58 1-37
5-9 9-10 0-08 043 -
- 14-10 0-30 0-77 62
6-40 0-18 0-86 -
5-3 14-20 0-03 1-26 379
5-3 8-30 0-23 1-22
Prolactin
ng/ml
6 -54
4-98
6 00
7-92
8-6
4-8
* Serum pools from groups of 5-10 animals.
Age of
mice
(days)
120
120
120
120
150
150
210
210
240
240
240
240
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TABLE V.-Prevention of DMBA-induced Lymphosarcomas in SJL/J Mice by Mas-
culinization
Lymphosarcoma Reticulum cell neoplasms
Host
treatment
Controls
Masculinization
DMBA
Masc. +DMBA
- ~
Incidence
0/55=0%
0/75=0%
55/67=82%>()
10/42=23%>(< 01)
ALP (days) Incidence ALP (days)
51/55=93% 292
58/75=77% 311
128 (P<0-05)t 7/67-10% 202
171>(<.5t 17/42 =40% 257
* X2 test.
t Mann-Whitney test.
mice. This isolated finding remains un-
explained.
Experiment 5
Incidence of LS in DMBA-treated
female SJL/J females was strikingly
reduced when these mice were masculin-
ized and rendered sterile by administra-
tion of testosterone (TP) in the first 3
days of life. Also the ALP for onset
of LS was significantly prolonged (Table
V). It is noteworthy that a large number
of the SJL/J mice in which masculiniza-
tion prevented onset of DMBA-induced
LS later developed RCN-B, for which
the ALP was shortened (Table V).
Experiments 6, 7 and 8
Table VI summarizes the results
obtained in the experiments in which
CR females were masculinized and/or
treated with DMBA, treated with DMBA
and/or gonadotrophins (HCG). These al-
bino mice generally show a very low
incidence ofspontaneous tumours. DMBA
feeding per se induced in CR mice a very
high incidence of tumours (40 tumours in
37 mice) with short ALP (200 days).
These tumours were carcinomas (14/40 -
35%; mostly squamous-cell carcinomas
of the stomach with precocious skin
metastases) and ovarian tumours (16/40 -
40%, 15 of which were granulosa-cell
tumours, all with lung metastasis), but
only a few were systemic neoplasms
(4/40 - 10%; 3 lymphosarcomas and 1
plasmocytoma). Masculinization per se
induced only a very late onset of fewer
tumours (33%, with ALP of 592 days).
Oral feeding with DMBA in previously
masculinized CR mice increased the in-
cidence of systemic neoplasms (6/16 -
37%; 4 LS, 1 RCN-B and 1 undifferen-
tiated stem-cell sarcoma) relative to mice
treated with DMBA only. Continual
TABLE VI.-Effect ofDMBA, Masculinization and Gonadotrophins on GenesisofTumours
in CR Females
Host
treatment
Tumour
incidence/
group
Untreated 3/16= 19%
Masculinization 7/21 =33%
DMBA 29/37=78%
Masc.+DMBA 13/20=65%
DMBA+Gonado- 18/19 =95%
trophins
Gonadotrophins 11/16=69%
Total
tumours/
group
3
8
40
16
25
ALP*
540
592
203
209
211
Negative
or death
from
unknown
causes
13
14
8
7
1
More frequent malignant tumours
Systemic
neoplasia
1/3=33%
3/8=37%
4/40= 10%
6/16=37%
6/25=24%
Carcinomas
1/3= 33%
1/8= 12%
14/40=35%t
2/16= 12%t
7/25=28%t
Ovarian
tumours
0/16=0%
3/8=37%
16/40 =40%
5/16= 30%
9/25= 36%
13 440 5 8/13=61% 3/13=23% 0/13=0%
* ALP is measured from the first feeding in DMBA-treated mice, and from day of birth in the other
groups.
t Mostly squamous, cell carcinomas of the stomach.
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TABLE VII.-Changes of Hormone Levels in Peripheral Blood of CR Females Consequent
to Masculinization and/or Oral Treatment with DMBA
Treatment
Normal
Masoulinized
DMBA
Masc.+DMBA
Normal
Masculinized
DMBA
Masc. +DMBA
Normal
DMBA
Normal
Masculinized
DMBA
Masc. +DMBA
Normal
Masculinized
DMBA
Masc.+DMBA
Age
(days)
70
70
70
70
150
150
150
150
180
180
210
210
210
210
360
360
360
360
Thyroxine
jig/100 ml
10-7
10-5
10 -2
10-0
Progesterone
4Ig/100 ml
2-73
0-36
1-80
0 30
0-68
0 20
0 25
0-10
0 53
7-9 1-00
14-1
9-8
9-7
10-8
1-20
0-88
1 -72
1 -17
17-fl-Oestradiol
nM
0 30
0-61
0-62
0 48
0 50
0 45
0 42
0-38
0 46
0 09
0-10
0-10
009
0 24
inoculation of gonadotrophins in DMBA-
treated mice induced slight differences in
incidence of systemic neoplasms, car-
cinomas and ovarian tumours. Finally
and most interestingly, chronic adminis-
tration of gonadotrophins alone into
normal CR females induced a high inci-
dence of systemic neoplasms (8/13=
61%; 5 LS, 2 RCN-A (Dunn, 1954) and
1 erythroblastic leukaemia). Determina-
tions ofhormones in the blood (Table VII)
showed that DMBA treatment induced
in CR mice an increase in levels of cortico-
sterone at 70 days of age and a reduction
in levels of progesterone at 70 and 150
days of age. Masculinization also drastic-
ally reduced the levels of progesterone
and therefore acted, in this respect,
synergistically with DMBA. However,
contrary to DMBA-treated SJL/J mice,
in which the level of corticosterone was
much lower than that of control groups
already at 240 days of age (Table IV),
the higher levels of serum corticosterone
in DMBA-treated CR mice were main-
tained later in life (360 days of age) and
the levels of progesterone were higher
than those of controls at 180 and 210
days of age (Table VII). As already
seen in Table IV, DMBA treatment
produced a very sharp increase in LH
levels. Therefore, the effects induced by
DMBA in SJL/J mice were fully confirmed
by those induced in CR mice (Table VII).
DISCUSSION
The findings in this investigation do
not supply a definitive proof that a
well-defined, congenital or induced hor-
monal derangement (e.g., a constantly
high level of gonadotrophins and a pro-
gressive corticoadrenal insufficiency in
mice developing systemic neoplasms) is
directly related to carcinogenesis (Pier-
paoli et al., 1974). However, they suggest
a prominent role for induced long-term
endocrine imbalance in leukaemogenesis,
and permit the identification of some of
the hormones which are primarily in-
volved and changed in response to
DMBA. In addition, they indicate that
the host's specific genetic background
determines the extent to which resistance
is offered to the permanent hormonal
changes induced by the carcinogen, and
the relevance of this interplay for the
onset of leukaemia. This situation is
LH
ng/ml
Corticosterone
jug/100 ml
7 -98
7 40
10-60
10-90
7-1
7 0
14-8
11 -3
55
47
120
42
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exemplified by the difference between
the SJL/J and CR strains of mice. In
both strains, DMBA treatment elevated
levels of LH and corticosteroids and
decreased those of progesterone (Table IV
and VII), but, while the adrenal and
gonadal function, expressed as release
of corticosteroids and gonadal steroids,
was already impaired in the SJL/J mice
at 8 months of age (Pierpaoli et al.,
1974; Table IV), this function was still
normal in 1-year-old CR mice (Table
VII). It seems, therefore, that the con-
sequence of this different genetic sensi-
tivity of the neuroendocrine system in
these two strains of mice to the same
carcinogen is the appearance of an
elevated number of LS in SJL/J mice
and of carcinomas and ovarian tumours
in CR mice. The well-known protective
action of corticosteroids against leuk-
aemogenesis protects CR mice, but does
not protect them from carcinoma and
ovarian tumours. That this hormonal
interplay is critical for leukaemogenesis
is illustrated by the experiment in which
the SJL/J female mice were either gonad-
ectomized (Table III) or in which a
permanent sterilization and virilization
were induced by one neonatal injection
of testosterone (Table V). These pro-
cedures profoundly affect the mechanisms
of synthesis and/or release of gonado-
trophin-releasing factors in the hypo-
thalamic centres, and permanently alter
the cyclicity of females (Barraclough and
Leathem, 1954; Barraclough, 1961a, b).
It is certain that gonadotrophins (GTH)
release is increased in both cases, and the
findings are in conformity with the view
of Gardner (1953) that hormonal carcino-
genesis requires not only an ongoing
hormonal imbalance, but also that cyclical
or intermittent changes be replaced by
continuous action.
As expected from the negative experi-
ments of Silberberg, Silberberg and Leid-
ler (1951), chronic administration of
GTH does not induce ovarian tumours,
hut does strongly promote the onset of
systemic neoplasms (Table VI). This
is in apparent contrast to the action
of DMBA in increasing levels of GTH
in SJL/J mice. The latter confirms the
concept that it is the continued alteration
of the normal physiological, age- and sex-
associated male/female endocrine status,
andnotthespecificalterationofone or more
hormonal functions, which is responsible
for onset of tumours. On the basis of
these and previous findings (Haran-Ghera,
1973; Pierpaoli et al., 1974; Pierpaoli and
Haran-Ghera, 1975), the possibility is
considered that the main primary action
on host milieu of some carcinogenic
hydrocarbons such as DMBA is that
of creating a permanently disturbed
endocrine environment which, together
with other environmental or viral factors,
would allow the " dormant " preleukaemic
cells, ubiquitous in organs of healthy
animals (Haran-Ghera, 1973), to escape
the particular kind of proliferative control
exerted by the normal, sex-specific hor-
monal status. Such a general concept
of the primary role of endocrine derange-
ment on oncogenesis finds support from
varied data in the literature. It seems to
be valid at least for tumours from tissues
in which the original hormone-dependence
appears more relevant, such as mammary
carcinoma (Muihlbock and Boot, 1959;
Mittra and Hayward, 1974a, b; Sinha,
Selby and Vanderlaan, 1974; Pierpaoli
and Sorkin, 1972a; Papaioannou, 1974)
and systemic neoplasms of the reticulo-
endothelial and lymphatic tissues (Lacas-
sagne, 1937; Kirschbaum, 1951; Pierpaoli
et al., 1974; Pierpaoli and Haran-Ghera,
1975).
These findings on the increased blood
level of LH which preceeds the onset
of LS in DMBA-treated mice are in-
directly confirmed by another striking
example of the basic role of hormonal
derangements in oncogenesis. It is well
established that removal of the thymus
prevents or delays the onset of mammary
carcinoma (MC) (Martinez, 1964) and
X-ray- or carcinogen-induced leukaemia
in mice (Kaplan, 1950; Law and Miller,
1950). Recent work has demonstrated
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that, in early ontogeny, the thymus
participates in the organization of the
hypothalamic centres for gonadal and
adrenal functions (Pierpaoli and Sorkin,
1972b; Pierpaoli and Besedovsky, 1975).
Blood levels of LH are sharply increased,
and those of prolactin are extremely
low, in the blood of athymic nude mice.
The abnormal blood levels of these two
hormones can be normalized by thymus
implantation at birth (Pierpaoli, Kopp
and Bianchi, 1976). It is therefore evi-
dent that perinatal thymectomy pro-
foundly influences the mechanisms of
synthesis and/or release of prolactin and
LH, with possible consequent inhibiting
action on onset of spontaneous MC in
C3H female mice (with lower levels of
prolactin). This leads to the suggestion
that a possible mechanism by which
thymectomy prevents or delays the onset
of MC or leukaemia in mice is not only
that of removing the target cells for viral
or other carcinogenic action, but also
that of modifying or " normalizing "
those well defined abnormal hormonal
conditions which are characteristic of
mice which develop MC (with higher
levels of prolactin) or DMBA-induced LS
(higher levels of LH). However, the fact
that thymectomy produces an increase
in LH levels and prevents leukaemia is
in contrast with the simplistic idea that
only a quantitative and permanent hor-
monal imbalance promotes oncogenesis.
It rather confirms the view of Gardner
(1953) that a permanent disturbance of
the physiological cyclicity of endocrine
functions is potentially carcinogenic.
It seems that transformation of cells
to malignancy is a very early and common
event, at least in chemically induced
murine leukaemia, but that these " dor-
mant " pre-leukaemic cells are controlled,
and do not proliferate (Haran-Ghera,
1973). Any event of a genetic, age- or
sex-dependent, or environmental nature
might change this condition in a perma-
nent way, and allow the tumour cells
to proliferate. This does not seem to
be true for the spontaneous RCN in
SJL/J mice, where castration and/or
thymectomy could not significantly delay
the onset, or decrease the incidence of
the disease (Table II). The congenital
deficiency of adrenocortical function in
these mice (Pierpaoli et al., 1974) might be
responsible.
The experimental findings emerging
from this work are relevant to, and
warrant the study of, hormonal derange-
ments in Hodgkin's disease and human
leukaemias. They indicate that a per-
manent imbalance between adrenal ste-
roids and GTH may be required for
genesis of systemic neoplasms and that
a chronic shift of the equilibrium towards
increased GTH and decreased cortico-
steroids is probably most dangerous in
favouring their onset (e.g., X-irradiation,
chemical carcinogens, etc.). All proce-
dures changing this balance may therefore
be potentially carcinogenic. The same
is probably true for prolactin and the
genesis of MC. Consequently, it would
be most interesting to establish how
frequently a congenital or acquired central
alteration of neuroendocrine regulation
is primarily involved in oncogenesis in
humans, as compared to the permanent
derangements of peripheral endocrine
glands induced by other factors (viruses,
infections, etc.).
We thank Dr M. Keller, Hoffmann-La
Roche & Co., Diagnostica, Schweizerhalle,
Switzerland, for the determinations of
thyroxine, testosterone, corticosterone,
progesterone and 17-,f-oestradiol, and Dr
H. Berchtold, Biostatistics Centre, Faculty
of Medicine, University of Zurich, for
the statistical analysis. The invaluable
help of Dr A. Meshorer, the Weizmann
Institute of Science, Rehovot, Israel,
contributed to the exact classification
and diagnosis of the mouse tumours.
We gratefully acknowledge the technical
assistance of Miss R. Kellerhals, J. Eisele,
I. Looser and K. Naumann. This work
has been supported in part (W.P.) by
the Swiss National Fund for Scientific
Research, Grant No. 3.8750.72.
628HORMONES AND MURINE LEUKAEMOGENESIS 629
REFERENCES
ABRAHAM, G. E. (1969) Solid-phase Radioimmuno-
assay of Estradiol- 17. J. clin. Endocrin., 29,
866.
ABRAHAM, G. E. (1974) Radioimmunoassay of
Steroids in Biological Materials. Acta endocrin.
(Kbh), Suppl., 183, 1.
BARRACLOUGH, C. A. (1961a) Production ofAnovula-
tory Sterile Rats by Single Injection of Testo-
sterone Propionate. Endocrinology, 68, 62.
BARRACLOUGH, C. A. (1961b) Evidence that the
Hypothalamus is Responsible for Androgen-
induced Sterility in the Female Rat. Endocrin-
ology, 68, 68.
BARRACLOUGH, C. A. & LEATHEM, J. H. (1954)
Infertility Induced in Mice by a Single Injection
of Testosterone Propionate. Proc. Soc. exp.
Biol. Med., 85, 673.
Buus, 0. (1968) Double Isotope Technique for
Determination of the Individual Corticosteroids
in Human Plasma. Excerpta med., 157, 107.
DALE, E. & SCUTCHFIELD, F. D. (1968) Adrenal
Lipid and Plasma Corticosterone Depletion after
7,12-dimethylbenz(a)anthracene Administration
to the Albino Rat. Experientia, 24, 723.
DUNN, T. B. (1954) Normal and Pathologic Anatomy
of the Reticular Tissue in Laboratory Mice,
with a Classification and Discussion ofNeoplasms.
J. natn. Cancer In8t., 14, 1281.
GARDNER, W. U. (1953) Hormonal Aspects of
Experimental Tumorigenesis. Adv. Cancer Res.,
1, 173.
HARAN-GHERA, N. (1973) Relationship between
Tumor Cell and Host in Chemical Leukemogenesis.
Nature, New Biol., 246, 84.
HARAN-GHERA, N., KOTLER, M. & MESHORER, A.
(1967) Studies on Leukemia Development in
the SJL/J Strain of Mice. J. natn. Cancer Inst.,
34, 653.
KAPLAN, H. S. (1950) Influence of Thymectomy,
Splenectomy and Gonadectomy on Incidence
of Radiation-induced Lymphoid Tumors in
Strain C57BL Mice. J. natn. Cancer Inst.,
11, 83.
KIRSCHBAUM, A. (1951) Rodent Leukemia: Recent
Biological Studies. Cancer Res., 11, 741.
KRARUP, T. (1970) Effect of 9 : 10-dimethyl-1 2
benzanthracene on the Mouse Ovary. Acta
endocr., 64, 489.
LACASSAGNE, A. (1937) Sarcomas Lymphoides
Apparus chez des Souris Longuement Trait6es
par des Hormones Oestrogenes. C. r. Seanc.
Soc. Biol., 126, 193.
LAW, L. W. & MILLER, J. H. (1950) The Influence
of Thymectomy on the Incidence of Carcinogen-
induced Leukemia in Strain DBA Mice. J.
natn. Cancer Inst., 11, 425.
MARTINEZ, C. (1964) Effect of Early Thymectomy
43
on Development of Mammary Tumours in
Mice. Nature, Lond., 203, 1188.
MITTRA, I. & HAYWARD, J. L. (1974a) Hypo-
thalamic-pituitary-thyroid Axis in Breast Cancer.
Lancet, i, 885.
MITTRA, I. & HAYWARD, J. L. (1974b) Hypothala-
mic-Pituitary-Prolactin Axis in Breast Cancer.
Lancet, i, 889.
MUHLBOCK, 0. & BOOT, L. M. (1958) The Mechanism
of Hormonal Carcinogenesis. In Ciba Foundation
Symposium on Carcinogenesis. Mechanisms of
action. London: Churchill, p. 83.
MURPHY, E. D. (1963) SJL/J, a New Inbred Strain
of Mouse with a High, Early Incidence of Reti-
culum-cell Neoplasms. Proc. Am. A8s. Cancer
Res., 4, 46.
MURPHY, B. E. P. & JACHAN, C. (1965) The Deter-
mination of Thyroxine by Competitive Protein-
binding Analysis Employing an Anion Exchange
Resin and Radiothyroxine. J. Lab. clin. Med.,
66, 161.
MURPHY, B. E. P., PATTEE, C. J. & GOLD, A. (1966)
Clinical Evaluation of a New Method for the
Determination of Serum Thyroxine. J. clin.
Endocrin., 26, 247.
PAPAIOANNOU, A. N. (1974) The Etiology of Human
Breast Cancer. Berlin: Springer Verlag.
PIERPAOLI, W. & BESEDOVSKY, H. 0. (1975) Role
of the Thymus in Programming of Neuroendo-
crine Functions. Clin. exp. Immunol., 20, 323.
PIERPAOLI, W., HARAN-GHERA, N., BIANCHI, E.,
MULLER, J., MESHORER, A. & BREE, M. (1974)
Endocrine Disorders as a Contributory Factor
to Neoplasia in SJL/J Mice. J. natn. Cancer
Inst., 53, 731.
PIERPAOLI, W. & HARAN-GHERA, N. (1975) Pre-
vention of Induced Leukemia in Mice by Immuno-
logical Inhibition of Adenohypophysis. Nature,
Lond., 254, 334.
PIERPAOLI, W., Kopp, H. G. & BIANCHI, E. (1976)
Interdependence of Thymic and Neuroendocrine
Functions in Ontogeny. Clin. exp. Immunol.,
24, 501.
PIERPAOLI, W. & SORKIN, E. (1972a) Inhibition
of Growth of Methylcholanthrene-induced Mam-
mary Carcinoma in Rats by Anti-adenohypo-
physis Serum. Nature, New Biol, 238, 58.
PIERPAOLI, W. & SORKIN, E. (1972b) Alteration
of Adrenal Cortex and Thyroid in Mice with
Congenital Absence of the Thymus. Nature,
New Biol., 238, 282.
SILBERBERG, M., SILBERBERG, R. & LEIDLER, H. V.
(1951) Effects of Anterior Hypophyseal Trans-
plants on Intrasplenic Ovarian Grafts. Cancer
Res., 11, 624.
SINHA, Y. N., SELBY, F. W. & VANDERLAAN,
W. P. (1974) The Natural History of Prolactin
and GH Secretion in Mice with High and Low
Incidence of Mammary Tumors. Endocrinology,
94, 757.